StonvexLoading…
StonvexCore line items from RC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $569.17M | $896.98M | $945.81M | $663.22M |
Operating Income | $-302.56M | $-516.51M | $358.42M | $175.03M |
Net Income | $-221.06M | $-430.40M | $348.41M | $203.16M |
EPS (Diluted) | $-1.44 | $-2.63 | $2.22 | $1.65 |
Total Assets | $7.77B | $10.14B | $12.44B | $11.62B |
Total Liabilities | $6.12B | $8.20B | $9.79B | $9.72B |
Cash & Equivalents | $207.84M | $143.80M | $138.53M | $147.40M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 163.01M | 162.79M | 172.28M | 110.52M |